Natural molecule discovery, industrialized Natural products have contributed more than 500 molecules to pharmaceuticals. However, conventional methods for discovering new natural products are increasingly ineffective. Generare has developed a revolutionary platform that identifies and expresses a wide range of naturally occurring secondary metabolites, selected by millions of years of bacterial evolution. This platform allows us to reintroduce these lead molecules into clinical pipelines, reopening a validated avenue for therapeutic innovation. genomics, synbio, and microbiology

100 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells. LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. By decoding the language of the neuroimmune cross-talk, we are developing first-in-class therapeutic products – NRILs: neuronal reprogrammers of innate lymphocytes - to preserve health and treat inflammatory, infectious and metabolic diseases. We are bridging neural sensing and immunology discoveries to unlock therapeutic solutions for the benefit of patients.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We create ophthalmic therapeutic bio factories to sustainably treat major eye diseases. Eyevensys is a clinical stage, private, biotechnology company developing its innovative EyeCET platform to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophthalmic disease. EyeCET stands for the eye ciliary muscle electro-transfection technology, which uses electroporation to deliver plasmids coding for therapeutic proteins in the eye. EyeCET is safe and non-viral, and it enables the ciliary muscle cells to sustainably produce therapeutic proteins locally. Eyevensys believes its EyeCET technology can improve short and long-term therapeutic outcomes, greatly enhancing patient compliance and significantly …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

PulseSight is an ophthalmology drug development company developing disruptive non-viral gene therapies with minimally-invasive delivery technology to treat major eye diseases. Our mission is to develop life-changing solutions for patients with diseases leading to sight loss.

83 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Aptamarker Platform | High-Plex Proteomics | Biomarker Discovery | Advanced DNA Aptamer Library & Machine Learning At NeoVentures Biotechnology Europe we are committed to revolutionizing the biopharmaceutical field through a cutting-edge biomarker discovery platform, propelling the industry towards personalized medicine with rapid, cost-effective, and automated processes for biomarker discovery and validation. Our Aptamarker platform leverages a library of 16.8 million DNA aptamers to analyze epitope profiles in biofluids, liquid biopsy or tissue, facilitating the precise measurement of surrogate biomarkers and expediting the creation of predictive In Vitro Diagnostic (IVD) tests tailored to distinct pathophysiological conditions. With our advanced DNA aptamer …

16 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Miravas is an innovative medical devices start up in varicose veins treatment Soon a new device for the treatment of venous disease in medical office setting, with combination of two complementary techniques, steam and radiofrequency Varicose veins treatment, Medical devices, and Thermal ablation

60 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Dermo-innovation Feeligreen is a technology startup developing safe and effective micro-current devices for a wide range of cosmetic and therapeutic applications. With applications ranging from anti-ageing to wound healing, it develops and sells innovative drug-delivery systems to TIer1 pharmaceutical laboratories medical devices, therapeutics, cosmetics, and skincare

134 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

"Health - Education - Digital": this is Zippyware's leitmotif. Our mission? To ensure that each of us becomes an actor of our health thanks to interactive solutions. At Zippyware, we are convinced of the need for public health prevention and the major role of therapeutic education, in particular thanks to multimedia supports. Digital transformation creates great opportunities to allow as many people as possible to become an actor in your health. Thanks to our unique combination of medical, educational and technological skills, Zippyware offers fun, innovative, efficient e-health solutions that meet the specific needs of users. Our tools can contact …

38 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Inspired by nature - realized by science 🍏 Inspired by nature – Realized by science Designing ideas for added value In the fast-moving cosmetic industry, innovation is the most important factor as it enables us to deliver new claims, new efficacy tests, new applications, new biochemical findings, as well as new marketing and communication tools to effectively differentiate products. At Mibelle Biochemistry, our mission is to design the most innovative actives for our customers. Inspired by nature – realized by science Our scientists transform naturally derived plant compounds into truly functional bioactive cosmetic ingredients. Our R&D team makes use of …

36 similar entities Type: SMB Activities: cosmetics deeptech Technologies: Synthetic Biology

Exploring together! We support biopharmaceutical research with translational preclinical models. CYNBIOSE is France-based non-clinical research organization. Preclinical CRO, Pharmacokinetics, POC, Efficacy, Immunotherapies, Drug, Early tox, CNS, Infectious diseases, Respiratory diseases, Non clinical, CRO, PK, PD, and TK

69 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing therapeutics for diseases with impaired kidney function ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

ADDIDREAM is a french company dedicated to the medical additive manufacturing. Thanks to a 550 m2 production area of different medical adapted 3D printing technology, we offer innovate solutions for the healthcare industry. Our services include computing aided design (CAO), different types of biocompatible materials 3D printing, and post-treatment processes.

64 similar entities Type: Startup Activities: deeptech healthtech industry 4.0 manufacturing Technologies: 3D Printing Synthetic Biology

Developing Smart Molecules Against Superbugs

Type: Startup Activities: deeptech Technologies: Synthetic Biology IoT

Meddenovo offers a unique blend of AI technologies and molecular modeling to design cyclic peptide therapeutics. Meddenovo is advancing AI-driven drug discovery with a specialized technology platform designed specifically for cyclic peptides. Our platform can design cyclic peptides from scratch, even without prior experimental data, and incorporates cutting-edge technology to capture their chameleon-like properties, including cell permeability. This unique capability enables us to address previously undruggable targets with precision. Cyclic peptides are a transformative class of compounds in pharmaceutical research, offering the advantages of both small molecules and large biologics, such as exceptional binding affinities, stability, and specificity. Technological advancements …

10 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

Trustworthy development and commercial manufacturing of CELL&GENE therapies On december 1st 2023, Seqens completed the acquisition of CELLforCURE. Originally a versatile CELL&GENE CDMO, CELLforCURE gained thorough experience in commercial CAR-T cells manufacturing. With 2 200m2 GMP production areas, 6 equipped production suites and 180 seasoned highly skilled experts, CELLforCURE offers versatile and flexible capacities. Located in France, 20km away from the Paris Orly Airport, CELLforCURE is an EMA approved production site and is compliant with FDA standards. The site brings analytical, development and regulatory services to serve client needs across the overall product life cycle. CELLforCURE teams aim at partnering …

21 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology

We supply the world with active pharmaceutical ingredients. PharmaZell offers a focused portfolio of small molecule APIs, together with custom development and manufacturing services for the generic and originator pharmaceutical industry. The company operates at three production sites, one in Germany and two in India. As part of the PharmaZell Group, the company employs 750 employees worldwide. Developing route of synthesis for API´s. Generic or NCE.

4 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology

We supply the world with active pharmaceutical ingredients Farmabios is a leading global manufacturer of highly potent active pharmaceutical ingredients. With decades of steroid and complex chemistry expertise, and newly opened research and development projects in various fields, Farmabios provides bespoke products and solutions, understanding customer needs. Steroids, Chemistry, Active Pharmaceutical Ingredients, Hormones, Drug Substances, Healthcare, Pharmaceuticals, and Bespoke products

62 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

3-D Matrix is a medical device company that offers innovative peptide technology, revolutionising the way healthcare professionals manage oozing bleeding during surgery. Join our community of healthcare professionals: https://www.linkedin.com/groups/12920054/ Headquartered in Tokyo, Japan, 3-D Matrix has expanded across America, Europe, Middle East and Asia. The company collaborates with many researchers, surgeons, healthcare providers and distributors across the world to continually improve on our product. We keep patient outcome at our heart, operating on three main principles: agility, proactiveness and focus. Follow us on Twitter @3dm_emea Sign up to our newsletter for the latest clinical data and product announcements: https://news.3dmatrix.com/newsletter-subscription Medical …

47 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Designer and manufacturer of electro-medicine devices MAZET electronics designs and manufactures electronic products. Specializing in the medical sector, the company takes care for its customers the design and manufacture of complete products. It has also developed a range of products intended for physiotherapists and sold under its brand Mazet Santé. Medical device and electronic cards

93 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Your physiotherapy partner. Do not hesitate to contact us for more information! Mazet Health is a brand of the Mazet Electronic Group. Located on the Lignon platforms in Haute-Loire (near Saint-Etienne) for 40 years, the Mazet Electronique company has become an expert in the design and manufacture of 100% French medical devices. Our products benefit from CE MEDICAL 0459 certification and the ISO 13485 standard and are mainly dedicated to physiotherapy. You can also find us on Facebook and YouTube. Mazet Health is a brand of the MAZET ELECTRONIC Group. Based in Haute-Loire (Near Saint-Etienne) for Almost 40 Years, MAZET …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

ECHODIA offers a wide range of devices specifically adapted to ENT doctors and other healthcare professsionals ECHODIA is a company created in 2009 specialized in hearing assessment in the fields of otorhinolaryngology and neuroscience. It develops and markets several devices dedicated to auditory measurements, specifically adapted to ENT doctors and other healthcare professionals’ needs (hearing care professionals, school nurses, occupational doctors, hospitals, etc.). ECHODIA offers a wide range of screening and diagnostic devices made in France so that you can perform all your hearing tests. ENT, HEARING, MEDICAL DEVICES, OCCUPATION HEALTH, SCREENING, AUDIOMETRY, ABR, TEOAE, MENIERE DISEASE, OCCUPATIONAL MEDICINE, OTOACOUSTICS …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

A sustainable delivery platform for oral biologics. Plantibodies is a biotech developing a sustainable platform to produce and deliver oral biologics with increased efficacy and less adverse side effects for the patients. Thanks to molecular farming and synthetic biology, our technology enables to produce humanized monoclonal antibodies within edible plant leaves instead of using animal cells, while drastically reducing carbon footprint, slashing production costs by over 90%, and offering medications with remarkable room temperature stability. By effortless storage and a potential worldwide distribution to treat diseases at home such as cancers, inflammations, metabolic diseases and infections, Plantibodies avoids burdensome intravenous …

Type: Startup Activities: deeptech Technologies: Synthetic Biology

A New Hope for Hemorrhagic Stroke Op2Lysis develops new treatments for patients suffering from thrombosis at the cerebrovascular level, with an initial focus on the hemorrhagic form of stroke. Indeed, there is no currently approved and available therapeutic solution for these patients. The company develops its game-changing NANOp2Lysis platform, associating a breakthrough vectorisation technology, industrial know-how enabling clinical quality production, and preclinical expertise to propose predictive and translational models, a first in this field. O2L-001, the first product resulting from this technology, will soon enter regulatory toxicology with the aim of applying for clinical trial authorisation in patients in North …

34 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Innovating for cancer patients METHYS Dx develops innovative liquid biopsy tests for non-invasive monitoring of cancer patients. Combining unique proprietary molecular signatures and a disruptive ultrasensitive detection technology, METHYS Dx tests will allow monitoring of tumor evolution, and early detection of relapses, thus improving patient care through better-informed therapeutic decisions. ctDNA, Cancer, Biomarqueurs, circulating tumoral DNA, Liquid biopsy, Precision medicine, and ddPCR

13 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

The world leader in the separation of proteins using innovative electrophoresis systems Sebia France is a subsidiary of the Sebia group. Founded in 1967, Sebia is a global player specializing in in vitro diagnosis for screening and monitoring of various diseases, mainly in the fields of oncology (multiple myeloma), diabetes, hemoglobinopathy, autoimmunity and other rare pathologies. Sebia's mission is to provide powerful tools that translate what is happening in a patient's body in legible and interpretable language. We call it our new language of life. Based in the south of Paris (Lisses, France), we have established strict standards to make …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

The future of mRNA bioproduction. ByoRNA uses eucaryotic cells as natural biofactories to make high-quality messenger RNA (mRNAs). Our bioproduction technology will help mass produce mRNA and enhance productivity at a fraction of the current cost. By perfecting an overlooked mRNA production method, we are helping build a more sustainable planet, save cancer patients and give their grand-children a future.

8 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Essential for Life Bienvenue Sur La Page Linkedin Aguettant France! Aguettant est un laboratoire pharmaceutique family français, dédié au développement, à la fabrication et à la Commercialization de Spécialités pharmaceutiques injes utilisées ou Initiées à l'hôpital. Aguettant Met Son Expertise Au Service You Progrès et de l'Inovation Médical Pour Concevoir Les Solutions Thérapeutiques de Demain. Retrouvez Sur Cette Page Toute L'Actualité d'Aguetant France. Anesthésie - Réanimation, Nutrition Parentérale, Produits Injectables d'Irgence, Maladie de Parkinson's, and spasticite

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Unlocking microalgae potential Unlocking microalgae potential ● EIT Food Seedbed Incubator (2023 Cohort) ● "Deeptech" certified by French Public Investment Bank (BPI) #microalgae #alternativeprotein

73 similar entities Type: Startup Activities: foodtech Technologies: Synthetic Biology

A nature-inspired solution to trap pathogens @AIS Biotech (with AIS for Anti Infective Sugar) is a French Biotech company based in the @Région Auvergne-Rhône-Alpes, France, incorporated in March 2023 with the objective of developing a new class of sugar-based anti-infective biotherapeutics to fight (re)emerging infectious diseases. Thanks to a Bioengineering plateform based on the expertise of the leading edge academic laboratory @CERMAV (@CNRS, @UGA, Grenoble, France), AIS Biotech aims to develop a pipeline of innovative sugar-based biopharmaceuticals which can prevent or treat infections by mimicking the natural host surface oligosaccharide binding-sites of pathogens. GlycoFlu, our first drug-candidate validated at the …

68 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

From Molecules to Medicine and Beyond NMR-Bio is a CRO located in Grenoble (France), one of the most vibrant European hubs for structural biology and supplies compounds for the selective labelling of methyl groups in perdeuterated proteins. NMR-Bio also offers a broad range of services for NMR applications: - Custom labelled protein production in bacteria, cell-free system, insect cells, HEK293 and CHO cells - Solution for labelling of your biopharmaceutics especially mAbs and Fabs - High-field NMR data acquisition and analysis (e.g. quality control, spectra assignment, structure calculation, dynamic characterisation).

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Digital & amp; Therapeutics native Creator of Digital Solutions for therapeutic Pathway e-health, medical remote monitoring, television, software, and care courses

Type: Startup Activities: healthtech deeptech Technologies: SaaS Synthetic Biology

Manufacture and sales of medical drugs, etc.

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Cancer monitoring made easy 🩸OncosemaTM️ is a purpose-driven company. Our mission is to dramatically improve the management of cancer patients by providing simple and non-invasive tools, to assist oncologists in making the best informed decisions for each patient. 🩸OncosemaTM️ is a deeptech start-up. We operate an exclusive technology targeting cancer-specific biomarkers, allowing the quantification and the isolation of Circulating Tumor Cells (CTC) from most types of cancer. 🩸OncosemaTM️ is focused on providing impactful tests for Oncology. ✔️Non-invasive ✔️Sensitive and specific ✔️Easy-to-use OncosemaTM️ is a registred trade mark of Oncocellex. Cancer, Diagnostic, Circulating Tumor Cells, Immunodiagnostic, Liquid Biopsy, Medical research, Patients …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Nanomedicine For Precision Radiotherapy NH TherAguix , a Phase 2 biotech company, has developed an innovative nano drug AGuIX® to improve cancer treatment by radiotherapy to treat tumours and metastases. Its pharmacological properties and its mode of action by bio-distribution allow it to act in the heart of tumors and confer it a pan-cancer potential. AGuIX® is currently assessed in 4 Phase II randomized trials in brain metastases using either whole brain radiation therapy (NANORAD2, CHUGA, Grenoble, France) or stereo-radiosurgery (NANOBRAINMETS, Dana Farber Brigham Cancer Center, Boston, USA), in glioblastoma (NANOGBM, multicentric, Clermont Ferrand, France) as well as in pancreatic …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We help life sciences companies manage clinical, quality, and regulatory processes so they can focus on improving lives With offices in the US, Europe, Japan and Japan, Agatha is dedicated to helping the world’s Hospitals, biotechnology, pharmaceutical, contract research organizations and medical device firms optimize the management of their Quality, Regulatory and Clinical documentation and processes. With lower costs and faster on-boarding, Agatha delivers the best ROI on business applications for life sciences that are ready to use and easy to adopt. Agatha, Inc. is a strategic software solution provider to the healthcare and life sciences industry, providing SaaS-based business …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Breaking Resistance Barrier in Oncology. React Therapeutics is a French biotech which works to restore the effectiveness of anti -cancer treatments and to improve the quality of care provided to patients. Created in January 2023 in Grenoble, React Therapeutics aims to develop a new class of molecules capable of blocking the phenomena of multi -resistance in therapeutic failures. ➡️ Our mission: to work for and with patients in order to restore the effectiveness of their anticancer treatments and improve the quality of their care. ➡️ Our goal: to develop a new class of molecules capable of blocking the phenomena of …

5 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Our focus on service, quality, and reliability has made Advanced Instruments a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries for more than 65 years. Globally, we provide innovative technologies aligned with the needs of the markets we serve, helping to improve efficiency, enhance productivity, and ensure best-in-class performance. Our Solentim portfolio of best-in-class imaging and single-cell deposition technologies enables the clonal isolation, outgrowth, and characterization of the highest value cells for monoclonal antibody upstream development and cell and gene therapy. Our robust line of micro-osmometers is built specifically for …

76 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Bioactive Lipids: the Future for Breakthrough Therapeutics GAOMA Therapeutics is a biotech company specialized in the development of lipids derivatives as innovative therapeutic molecules. Lipids are a class of compounds that has been largely under-exploited, whereas it plays a key role in many medical conditions. GAOMA has the ambition to tap into the therapeutic potential of lipids. The company’s first drug candidate, GAO-3-02, is a novel patented active ingredient. It aims to address epilepsy and cognitive disorders, by targeting neuroinflammation and brain plasticity. In various preclinical experiments, GAO-3-02 has thus demonstrated its ability to limit seizures, protect and restore cognitive …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Stromacare is a pioneer in tumoral stroma immuno-modulation and develops a therapeutic mAb for the treatment of cancers StromaCare is opening a new therapeutic avenue by targeting the tumoral Stroma, which is known to play a key role in several solid cancers, with the objective to be essential in the numerous anticancer protocols of treatment. Stromacare won the Beatrice Denys Foundation 2021 Prize (Foundation for Medical Research). The company is located in Lyon, France. oncology and monoclonal antibody

8 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing life enhancing treatments for chronic respiratory diseases Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. We are led by a management team with an established track record in the discovery, development and commercialization of respiratory therapies. Verona Pharma is listed on the Nasdaq Global Market in the United States under the ticker symbol VRNA. We are headquartered in London, UK, and have offices in Raleigh and Savannah in the US. View our community guidelines here: https://www.veronapharma.com/vrna-social-media-community-guidelines Novel therapies for chronic respiratory diseases …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Founded in 2005, Graftys develops, manufactures and markets patented synthetic bone biomaterials, in particular new generations of resorbable calcium-phosphate cements, for reconstructive orthopedic surgery. The Company’s products are commercialized in more than 25 countries, including Europe and the United States of America, through distribution partnership. The objective of the Company is to expand the Company product lines by offering new versions of existing products and new products with enhanced regenerative properties. The Company is based in Belgium (Wallonia) and France (Nantes and Aix-En-Provence). bone graft substitutes, Bone void fillers, Orthopedics, Reconstructive orthopedic surgery, Trauma, Bone tissue engineering, Injectable bone substitutes, …

43 similar entities Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology

Take care of patients and the planet today for tomorrow! Chiesi is an Italian biopharmaceutical family group offering innovative therapeutic solutions to patients in 3 therapeutic areas: air (products and solutions for newborns from the adults in adults), rare (treatments for rare and ultra-rare diseases), Care (products and services in renal and hepatic transplantation and prevention, micronutrition) Bringing together more than 7,000 employees worldwide, Chiesi is present in France on the entire added chain -D, production, distribution and provision of health professionals and patients -with a turnover reaching more than 200M € in 2023. B-CORP certified, Chiesi is involved in …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Nourish your mind. *Closed company* Fedmind is a health application for therapeutic education of overweight or obesity patients. An actor in the field of prevention and in that of medical research, Fedmind works in order to offer different, complementary and global care of the disease. The application offers on a complete one -year program with online therapy to work on the causes of obesity, food education education and physical activity circuits adapted to overweight. With the help of a benevolent community through weekly support groups, monitoring by the care team via the application and Fedalert ', a tool to disarm …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Continuing education at the service of health professionals since 1980 Since 1980, the AFAR has been at the service of the training of professionals from public and private health establishments, social, medico-social establishments, local authorities and businesses. Today recognized as one of the main players in training in these sectors, the AFAR continues its commitment to professionals by offering in particular a supply of expertise in the fields of management, health and safety at work, mental health, disability and mediation. Responding to the objectives of national and regional health programs, our training actions and our DPC programs welcome more than …

Type: SMB Activities: edtech healthtech Technologies: Synthetic Biology

Act, innovate, support, moderate costs For 30 years, IMM has been alongside health professionals and has offered them medical devices that meet the highest standards of requirement. In a context of an aging population with constant rising health expenses and a growing home care request, our common goal is to allow patients to receive their treatment in the best conditions of safety and comfort. Being close to all health players, understanding the challenges of care allows us a referencing and a constant evolution of our devices to provide each of the latest technological advances and respond to health care trends. …

23 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

A reliable clinical development partner CRO, synchronizing endpoints with funding milestones, ensuring impactful trials 🤝ILife Consulting is an entrepreneurial CRO partner specializing in early-phase clinical development. With over 25 years of experience and more than 30 clinical trials supervised, our team of experts transforms clinical data into value-creating assets for your company. We support over 20 active clients, including leading biotechs such as ImCheck, Peptinov, Smart Immune, and Brenus Pharma, as well as prestigious clinical sites like Gustave Roussy. Our expertise in First-in-Human and Proof-of-Concept studies enables us to generate critical data that enhance the value of your assets and …

45 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Healthcare & Life Sciences communication agency Panacee is a communication agency specialized in health market. We deal with the main stakeholders of life sciences and medical area; #biotech, #medtech, #mhealth, #publichealth, #pharma Communication, Marketing, Santé, Scientifique, Sciences de la vie, Médical, Biotech, medtech, pharma, medical devices, Santé publique, identité visuelle, Digital, Print, réseaux sociaux, BtoB, professionnels de santé, chercheurs, and patients

150 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Music technology responsive to who you are and how you feel. Designed for therapeutic work. linktr.ee/wavepaths Wavepaths unifies immersive arts, psychotherapies and intelligent technologies into a new approach to well-being. Music, Art, Intelligent Technologies, Psychedelic Medicine, and Therapeutic

Type: Startup Activities: deeptech Technologies: Synthetic Biology

Developing technology for tomorrow's crops AgGene is an agriculture biotechnology company focused on the development of plant traits to address major challenges faced during crop production. Our flagship technology addresses the demand for improving protein content in plant tissues using advanced genomics and molecular plant breeding techniques including gene-editing. AgGene is also focused on collaborative relationships with other agriculture companies and independent plant breeders to help develop plant biotech traits to address issues including climate resilience. biotechnology, gene editing, agriculture, molecular genetics, molecular biology, genomics, genetic engineering, and plant biology

19 similar entities Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology

The Human-on-a-Chip Company Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Bringing together biologists, surface chemists, and engineers, our team is producing some of the world's most advanced organs-on-a-chip platforms. From gene expression to electrophysiology, we recreate key components of organs in an interconnected, functional system. Chemically patterned microchips enable real-time, non-invasive monitoring of organ function where we use sophisticated measurement techniques to detect minute changes. This breakthrough technology enables unprecedented visibility into specific disease states and how the …

38 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

DermTech, LLC provides genomic analysis of skin samples collected non-invasively using its Smart Stickers. DermTech develops and markets products to facilitate the assessment of melanoma. Melanoma, Gene Expression Testing, Pigmented Lesions, Dermatology, and Dermatopathology

32 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

The AFSA Collaboration works to accelerate the adoption of modern, human-relevant approaches to testing. The Animal-Free Safety Assessment (AFSA) Collaboration is a unique multi-sector partnership between non-profit, corporate, and philanthropic leaders working to advance acceptance and use of animal-free safety science as a gold standard across regulatory frameworks worldwide. AFSA brings together corporate, philanthropic and non-profit leaders who share the goal of accelerating a modern, species-relevant approach to safety assessment globally to better protect people and our planet, and hasten the replacement of animal testing. Our members cooperate on a range of educational and policy topics specific to the cosmetics, …

Type: Startup Activities: deeptech Technologies: Synthetic Biology

Building a biological platform to produce low-cost, sustainable omega-3 for aquaculture. Powered by Synthetic Biology. Powered by Synthetic Biology, Synthesea is developing synthesis technology that is transferable to a wide range of lipids (AKA fats). And we're starting with omega-3. Omega-3 oil is a necessity for fish to grow nutritiously and is naturally found in algae, which wild fish eat. Fish grown in aquaculture (farms for fish livestock) cannot eat algae due to scaling limitations. Therefore, the current solution is to feed wild-caught fishmeal (crushed fish) to aquaculture fish. This rapidly depletes wild fish stocks and is continuously increasing the …

Type: Startup Activities: deeptech Technologies: Synthetic Biology

Delicious alternative cocoa and coffee. Lipid alternatives. Food Brewer AG is a Switzerland based food and food ingredients company producing and selling cocoa and coffee alternatives. For our delicious products we use plant cell cultures and finest crops. We also develop pioneering technologies for large scale cultivation in fermenters (similar to beer brewing) as an alternative to conventional agriculture. Our ultimate mission is to secure key resources for the food industry while eliminating geographic, climatic, and ethical uncertainties. Biotechnology, Plant Cell Culture, Cellular Agriculture, Cocoa, Coffee, Nuts, Grains, Berries, Microalgae, Fungi, Mycelium, and Bioreactor

37 similar entities Type: Startup Activities: foodtech Technologies: Synthetic Biology

Innovative medicines to address haemato-oncology related life-threatening and rare diseases ElsaLys Biotech is a specialty pharmaceutical company, part of the Mediolanum Farmaceutici Spa group, focused on innovative medicines to address haemato-oncology related life-threatening and rare diseases. Following strategic acquisitions and targeted developments, ElsaLys is establishing an immunotherapeutic portfolio focused on niche specialty pharmaceuticals to answer unmet medical needs. Our commitment is to offer essential drugs meeting Public Health needs. Founded in 2013, ElsaLys Biotech is located in the heart of the European cluster Lyon Biopole, in Lyon, France. Anticorps thérapeutiques, Anticorps monoclonaux, Therapeutic antibodies, Monoclonal antibodies, ophtalmologie, immune microenvironment, vascular …

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

SLS France is a company being created in the Rennes area. This structure will allow the manufacture of chrome-cobalt dental prostheses by micro-fusion. Based on a multidisciplinary team competent in this technology, our desire is to offer a quality product that perfectly meets the needs of our future customers.

31 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: 3D Printing Synthetic Biology

🖇️ Oncofactory, a spin-off of the CNRS, is a science-driven biotech company that provides pharmaceutical and biotech companies with innovative in vivo services to support their non-clinical programs in oncology. Oncofactory joined the ERBC Group in December 2022 to extend its technology to a wider range of customers and provide a one-stop shop for non-clinical studies. 🥚Oncofactory unique technology platform is a New Approach Methodology (NAM) to generate patient tumor replicas in avian embryos (AVI-PDXTM), coupled with state-of-the-art 3D imaging and large-scale molecular analysis for rapid assessment of therapeutic efficacy and in-depth characterization of mechanisms of action to evaluate therapeutic …

5 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Bringing People & Ressources Together The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of patients in the field of rheumatology, dermatology and aesthetic. We believe that tomorrow medicine needs to be dedicated and targeted to patients. We aim to improve existing treatments by using non invasive processes allowing local and sustained administration of biological and active molécules. The company, incepted in 1998, has currently a staff of 11 people and is located in Sophia Antipolis (South of France). For …

58 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

e-Zyvec services by Polyplus provide tailor-made plasmids that really fit your needs! e-Zyvec is a French Biotech Start-up founded in 2016 as a spin-off of the University of Lille 1. We are providing unique solutions in molecular biology to academical or industrial scientists working on research project with genetic engineering applications. Using our proprietary DNA assembly technology and our in-house developped web application, we can design and produce fully customized gene expression vectors, fitting exactly the requirements of your project. Getting vectors with e-zyvec is fast, accurate and unrestrictive. Molecular Biology and Genetic Enginnering

8 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology

Breakthrough Solution for Respiratory Infections SIGNIA THERAPEUTICS is a research company based out of Bâtiment Adénine, 60 Avenue Rockefeller, 69008 Lyon, France

Type: Startup Activities: deeptech Technologies: Synthetic Biology A.I.

Dynacure is a clinical-stage company focused on developing novel therapies for rare diseases. Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Dynacure is developing DYN101, an investigational antisense product candidate designed to reduce the expression of dynamin 2 protein for the treatment of Myotubular and Centronuclear Myopathies, in strategic collaboration with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders, including its DYN201 program for the treatment of Hereditary Spastic Paraplegias. Dynacure is headquartered in …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

From Sea to Pharmacy ManRos Therapeutics is a biotech company identifying, optimizing and characterizing innovative, low molecular weight kinase inhibitors for the treatment of cystic fibrosis. ManRos was founded in 2007 and is led by Dr Laurent MEIJER, Chairman and CSO, former distinguished Director of Research at the CNRS, and Dr Philippe de Lavenne, CEO, former Vice-President at Actelion Pharmaceuticals. For 40 years, Dr Meijer dedicated his research to the study of protein kinases and their inhibitors, mostly at the CNRS. Drug Development, Cystic Fibrosis, and Biotechnology

60 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Ecrins Therapeutics is a biotechnology company which focuses on the discovery and development of novel anti-cancer compounds from the preclinical phase to phase II clinical proof of concept. In addition to the drug discovery, Ecrins Therapeutics provides a range of products and services for the benefit of our customers in biotechnology companies, universities, public research institutions and in the pharmaceutical industry. The mission of the commercial division of Ecrins Therapeutics is to help medical chemists and drug hunters to discover, characterize and advance their lead compounds through the drug development process. Visit http://ecrins-therapeutics-services.com/ for more information. Our research and production …

47 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Science Accelerated KCAS Bio - Lyon (Active Biomarkers) operates as a bioanalytical laboratory based in Lyon, France and headquartered in Olathe, Kansas, USA. We offer comprehensive service solutions for the development of both large and small molecules, with extensive capabilities and expertise in pharmacokinetics, immunogenicity, soluble and cellular biomarker analysis for clinical trials. Operating in state-of-the-art BSL2 facilities, our company is GLP certified and ISO 9001:2015 certified, with a unique track-record in the development, validation, and implementation of analytical methods. Our expert team has supported hundreds of studies in multiple therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases. …

57 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology Data Analytics

Advanced therapies inspired for you Defymed is a French SME that develops innovative medical devices aimed at treating patients physiologically in order to improve the clinical effectiveness of their treatment as well as their comfort. Defymed is a spin-off of the Centre européen d’étude du Diabète (European center for diabetes studies), which began work on a bioartificial pancreas in 1996. Today, Defymed focuses on diabetes, which is considered to be one of the major epidemics of the 21st century. There are currently two medical devices being developed by Defymed which are at an advanced preclinical trial phase: - #MailPan®: bioartificial …

Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Transforming cancer immunotherapy with next generation ADCs Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds. biotechnology, drug development, drug discovery, oncology, and R&D

70 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Together for our health OSCARE is the e-health solution for managing and organizing coordinated care pathways (ETP programs, HDJ/HDS, RAAC, SSR, etc.) for caregivers and their patients. OSCARE improves patient care by streamlining complex care pathways and making them actors in their health. Our digital service adapts to all pathologies or health themes: cancer, diabetes, obesity, maternity, Alzheimer's, Parkinson's, mental health, cardiology, pulmonology, tobaccology, pain management, etc. We meet a real national need in terms of prevention, diagnosis and health education. Come and discover our solution on www.os.care, or contact us for any questions at bonjour@os.care See you soon! e-health, …

57 similar entities Type: Startup Activities: edtech healthtech Technologies: Synthetic Biology

Improve the lives of children with CNS diseases Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children. Founded in 2009 by Karen Aiach, whose own child was affected by a neurodegenerative disease, Lysogene is rooted in a deep and compassionate understanding of the impact these diseases have on patients and families. Karen’s personal experience fuels her determination to deliver real solutions that will improve patient outcomes and enhance quality of life for both patients and caregivers. Over the past 10 years, Lysogene has acquired deep experience in developing gene therapies—from early …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Smart tools for cell biology Nanobiose’s mission is to provide pharma, biotech and cosmetic companies with better tools to improve their in vitro analysis of efficacy / safety of drug candidates. Nanobiose develops SecretCells®, an innovative lab-on-a-chip system to evaluate secreted biomarkers from 2D or 3D perfused cells. SecretCells® combines a microfluidic biochip (where the perfused 3D cell cultures stand) and a removable biosensor for a multiplexed on-line biomarkers analysis. While better mimicking in vivo like conditions, SecretCells® allows more accurate and more predictive results for the evaluation of drug candidates at early stages. SecretCells® is a very flexible solution …

Type: Startup Activities: biotech deeptech Technologies: Sensors Synthetic Biology

ArkAb is now Bcell Design! ArkAb is now Bcell Design! Bcell Design develops and manufactures chimeric monoclonal antibodies with human-like characteristics for in vitro diagnostics. We provide a secure and reliable source of raw material as a best alternative to disease state plasma and human serum, currently used as calibrators, positive controls or quality controls. Through its technological platform, built upon 15 years’ expertise in mAb and early-stage immunotherapy development, IVD developers and manufacturers gain access to a wide range of antibodies that are immediately ready for testing in human models. Founded in 2007 and from one of the few …

7 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

a NOVARTIS company CELLforCURE gathers all cell and gene therapies activities of the LFB group. With an annual production capability of several thousands of therapeutics batches, the Les Ulis CELLforCURE facility is the first modular entity in Europe to enable large scale industrial production for ATMPs. This platform operates on a mixed model of a CDMO (Contract Development and Manufacturing Organisation) providing large scale GMP and cGMP production services, for both clinical and commercial needs, and of a pharmaceutical company leading the development of cell and gene therapies medicinal products up to their launch on the market. CELLforCURE is an …

87 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

Focused on Excellence in Clinical Trial Operations ZMF RESOURCES is a French consulting company founded in 2012 and driven by two dedicated partners. We specialize in Clinical Research, Quality and Digital Consulting. We are located in the stunning Northern Alps near Mont Blanc. Proximity to Geneva, Switzerland, provides easy access to global markets via Geneva International Airport. Our values include: • Exceeding client expectations • A commitment to operational excellence, quality and continuous improvement • Transparency, agility, and proactiveness • Curiosity, creativity, and collaboration We invite you to explore how we can support your goals by visiting our websites. www.clin-ops.com …

Type: SMB Activities: it services Technologies: Synthetic Biology

Changing the world, one sequence at a time. Synbio Technologies aims to become the most trusted provider of DNA solutions that empower scientific discoveries by providing highly-accurate and cost-effective synthetic biology services and products for researchers around the world. We have developed a full range of DNA reading (sequencing), DNA writing (synthesis), and DNA editing (engineering) capabilities for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, biofuel implication, and more. Our scientific capabilities cover all facets of DNA synthesis and engineering, offering a full range of support for molecular biology …

76 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Real Dairy. No Cows. Here at Remilk, we’ve made it our mission to create real dairy without a single cow, bringing a message of hope and joy to our planet, our body... and cows!

Type: Startup Activities: foodtech Technologies: Synthetic Biology

Sustainable protein for the future of our planet Providing sustainable protein for a better future on this planet. Brevel's unique microalgae based protein is flavor and color neutral, has a full amino-acid profile, is highly functional and is affordable for the food industry. Brevel built it's first of a kind commercial facility with full scale systems and is now working with partners on expanding operations globally towards millions of tons of protein annually. Microalgae, Mixotrophy, Photobioreactor, Cultivation technology, Alternative protein, Protein, Dairy Alternatives, Egg Alternatives, and Meat Alternatives

8 similar entities Type: Startup Activities: biotech agritech Technologies: Synthetic Biology

Bridge-to-recovery by design Systol Dynamics designs and develops an innovative Ventricular Assist Device (VAD) that extends the benefits of mechanical circulatory support to less severe heart failure patients. Uniquely positioned in the aorta by transcatheter implantation, the Systol Dynamics’s VAD is at one minimally-invasive, connected and removable. Unlike terminal solutions, bridge to transplant or destination therapy, it relieves the patient’s heart and enables physiological recovery, ultimately leading to cardiac pump removal. Founded in 2018 by a cardiologist with more than 30 years of experience in the management of cardiac insufficiency, Systol Dynamics is managed by a team of experts in …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Research Contributing to Health and Well-Being: innovative polypeptides for the prevention & amp; Treatment of Pain Tafalgie Therapeutics is a spin-off company of the CNRS and AMU engaged in biopharmaceutical research and engaged in the development of a new scientific approach for new generation treatments based on a break in rupture: a mechanism of action derived from an endogenous secreted protein capable of modulating pain signals. Tafalgia Therapeutics wishes to become the reference actor in the field of pain, by designing and offering new pharmaceutical active ingredients based on the development of polypeptides derived from TAFA4. In Tafalgie Therapeutics, we …

3 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Shaping the future of in vitro preclinical research Unique R&D platform of donor-derived real human adipose tissue ex vivo for pharmaceutical drug development (obesity, chronic metabolic diseases), dermo-cosmetic, nutraceutical, aesthetic and reconstructive surgery research. ExAdEx-Innov owns exclusive worldwide rights to ExAdEx patented breakthrough technology from French academic laboratories of excellence (Côte d’Azur University, Institut de Biologie Valrose, CNRS, INSERM, University Hospital of Nice) and is supported by SATT Sud-Est, IdEX Université Côte d'Azur, CNRS Innovation, Provence Côte d'Azur Business Incubator, Métropôle Nice Côte d’Azur and Eurobiomed Healthtech Accelerator. adipose tissue, cosmetic testing, research platform, in vitro, ex vivo, models, obesity, …

100 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Tailor -made external breast prosthesis. 3D medical device to replace the breast identical after breast cancer Custom external breast prosthesis. Prosthesis breast, external prosthesis after cancer breast, scan3D, 3D printing, and cao

12 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Advice, audit, Specialized Sante Industry Training - Medical devices, cosmetics, compl. food, med. CAP Compliance - Your regulatory business expert and CE marking for medical devices CAP Compliance is a consulting company dedicated to manufacturers of medical devices and in vitro diagnostic medical devices, specialized in regulatory support, training, audit and compliance with the requirements in force. Our mission is to support you in each key step in regulatory management, the implementation of quality management systems to obtain CE marking, while ensuring continuous adaptation to developments. We collaborate closely with industrialists from medical devices to ensure that their products meet …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Your smart way to compliance As a CRO, we help our customers provide patients with safe and effective medical devices through solutions tailored to their business and regulatory challenges. OUR VALUES Trust and quality are the hallmarks of the way we work and partner with our clients. OUR MISSION We help our clients provide patients with safe and effective medical devices. OUR VISION Cost effectiveness, time savings and management of regulatory constraints. Regulatory evolutions differ from one region to another: they have their own rules and requirements for medical devices. It is crucial to partner with a CRO that understands …

42 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

We employ the power of mycelium! Biohifas employs the power of mycelium and valorizes industrial side streams into the food. We are developing technology in 3 areas: - Side stream processing into food grade substrates. - Mycelium cultivation in solid state fermentation. - Raw material conservation. We are looking for curious minds, who are amazed by the great kingdom of fungi. Let's employ the power of mycelium and solve the problems that our world faces! fungi, side streams, mycelium, solid state fermentation, side streams, alternative proteins, meat alternatives, circular economy, climate change, industrial by-products, food and beverage, and start up

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Lab-in-a-cell-devices Dynamic film about cell sensing SPAchip® technology is based on intracellular silicon microchips printed with multiple fluorescent probes to analyse and monitor cellular pathways at real time intracellular processes. The cell-based assays based on SPAchip® are compatible with High Content Screening platforms and imaging analysers. Suspended planar arrays, single cell analysis, cell signaling, flow cytometry, vaccines, and immunothepary

66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Bring your research idea and we will make it happen SpacePharma is a unique powerhouse offering an affordable and accessible microgravity research, together with true innovation to R&D pipelines. Our mission is to become a world leader in providing simplified and valuable, end-to-end microgravity services and solutions for research. Microgravity is a disruptive opportunity for several major sectors: pharmaceuticals, biotechnology, chemistry and materials science. It provides companies and researchers with the ability to accelerate discovery processes for new drugs and vaccines, develop new crystals and materials and accelerate the study of human genome and origin of diseases. The potential scientific, …

2 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

🌊Seafood Alternatives - Clean. High Protein. Tasty. Happy Ocean Foods develops clean, high protein and tasty seafood alternatives that are better for you and the oceans. Our promise: ✅ Simple ingredients ✅ High protein ✅ Super tasty We love nature and are passionate about health and great food. We believe that each of us can make a difference in this world. If we change something in our behavior, it will automatically affect our immediate environment and make big waves. That is why we want to inspire people to rethink their eating habits, so that the nature we have will thrive …

Type: Startup Activities: foodtech Technologies: Synthetic Biology

Technologies for Efficient Tooling For more than 50 years we manufacture multi-cavity molds (>128) for drug delivery devices. plastique, moule d'injection, injection mold, medical, diagnostic, pharmaceutical, design control, and metrology

90 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune

398 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Transforming the way challenging diseases and conditions are treated. Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company, originally founded as Stemnion, Inc., is located in the heart of Pittsburgh near the Southside Works. Noveome is passionate about growing its business in Allegheny County and helping the region to become a world leader in biotherapeutic research and development. Noveome Biotherapeutics, Inc. is a dynamic biopharmaceutical company with an innovative platform technology that represents a paradigm shift in drug development. Unlike most drugs that are single molecules …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

🇫🇷 French designer and manufacturer since 1905 💪 For dental professionals | 🌍 World supplier The company Micro-Mega, whose original activity dates back to 1905, is recognized worldwide for the design, manufacture and marketing of medical devices intended for dental surgery. Its canal and shutter instruments, its hand and counter-angles and hygiene devices testify to its unique technical and scientific know-how and the impeccable quality of its endodontics products made in France. Medical, dentistry, dental, and endodontics

5 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

your partner for preclinical research Biossan : A French CRO dedicated to biomedical research Biossan helps its academic and industrial partners develop their innovations by performing preclinical trials under controlled conditions. Biossan specializes in evaluating medical devices, new techniques, and pharmaceutical products in healthy and pathological models. Conduite et accompagnement de projet de recherche, Organisation de formation, and Bien-être et expérimentation animale

89 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Research center & amp; Health development Bionoveo offers project leaders, industrial or academic, biological, technical and methodological skills and resources necessary for the development of new therapeutic and diagnostic strategies, as well as their production processes.

283 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Support health technologies throughout their maturation cycle. A network of expertise made up of reactive platforms, which respond to "why, when and how to carry out preclinical and clinical studies". The network aims to encourage initiatives and facilitate the realization of multidisciplinary and collaborative translational research projects in the field of medical devices, e-health and biomaterials. It is a national network bringing together academic expertise in regulation and evaluation at the service of the development of medical devices, e-health and biomaterials throughout their life cycle. These axes can expand according to the needs, strategic issues and network resources. Tech4Health is …

58 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

BIONEEDS INDIA PRIVATE LIMITED is a Bangalore based Contract Research Organization providing Integrated Discovery, Development and Regulatory Services to Pharmaceutical, Biopharmaceutical, Agrochemical, Industrial chemical, Herbal/Nutraceutical and Medical device companies. Accreditation/Certifications • National GLP Compliance Monitoring Authority (NGCMA), Dept. of Science and Technology, Government of India • Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry of Environment, Forests and Climate Change, GOI. • State Drug Controller as a Government approved Drug Testing Laboratory for carrying out tests on Drugs / Cosmetics and • Raw Materials used in their manufacture on behalf of licensees for manufacture …

109 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Ready -to -use cell bank, for research, for patients Lymphobank - Bank of ready -to -use cells, for research, for patients. Lymphobank is a biotech specializing in the supply of adult and placental -use -for -use blood cells, the characteristics of which will be available online (www.lymphobank.fr), allowing the cellular product to be chosen according to an interest donor. Our services are focused on the development of cellular immunotherapy products. In addition, Lymphobank develops an innovative approach to allogenic adoptive immunotherapy of hepatocellular carcinoma (the most frequent liver cancers and second cause of cancer death in the world, with nearly …

62 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Dedicated to developing treatments for rare diseases originated from nonsense mutations Genvade aims to harness the power of nonsense mutation readthrough molecules to develop treatments for some of the most burdensome rare diseases. Our lead compound targets indications include cystic fibrosis, Duchenne muscular dystrophy and other genetic diseases. small molecules, drug discovery and development, rare diseases, nonsense mutation corrector, cystic fibrosis, genetic diseases, oncology, readthrough, and Duchenne

101 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Cousin Surgery offers innovative implants around the world to advance visceral surgery and spine surgery. Cousin Surgery relies on unique expertise in the world of implantable textiles and great creativity, in close collaboration with surgeons. Our areas of innovation: preserve mobility and reduce postoperative pain. Cousin Biotech is the legal manufacturer of the medical devices proposed by Cousin Surgery. Textile medical devices, Spine surgery, Visceral surgery, Obesity surgery, Uro-gynaecology surgery, Hernia repair, and Manufacturing

10 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology

Find a home solution, whatever the age, level of dependence and health of patients. Recognized in public utility, Santélys is a non -profit establishment specializing in health, home care and training. Coordination, prevention, education, hospitalization, care, support, technologies, telemedicine and Télésuivi, at home and in proximity: the vocation of Healthlys is to find a solution at home, whatever the age, the level of dependence and the health of the patient suffering from a chronic pathology (renal failure, respiratory insufficiency, diabetes ...) or cancer. Training in nursing, training of caregivers, continuing education, Center for Patient Therapeutic Education Expertise ... Santélys trains …

19 similar entities Type: SMB Activities: healthtech edtech Technologies: Synthetic Biology

Seenel Imaging is dedicated to functional Neuroimaging technology. We launched in 2019 a breakthrough research device combining EEG & fNIRS further to 10 years of Academic research. Medelopt® is a wearable High Resolution NIRS/EEG device with unique features on the market. NIRS, EEG, Brain Imaging, Functional NIRS, Cognitive Research, Optical Imaging, Innovation, and Neuroscience

8 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

MedTech Startup providing innovative solutions in orthopedics Aidplex is an orthopedics company whose patient-centric products are revolutionizing the treatment and monitoring of orthopedic patients. Starting with Scoliosis treatment, Aidplex launched ScolioSense. ScolioSense is a patent-pending medical device designed to ensure the quality of scoliosis treatment by combining portability, accuracy, and assurance of the correct fitting of the back brace. Orthopedics, HealthTech, Patient-Centric solutions, Rehabilitation, scoliosis, medical devices, and quality assurance

7 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Spectrum Medical supplies Clinical Information Solutions that include Medical Device Connectivity Technologies, Electronic Medical Record Systems, Telemedicine Capabilities and Compliance and Patient Safety Solutions. Spectrum Medical also supplies Non-invasive Diagnostics Systems for extracorporeal procedures.

26 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology